The sixth annual international life science partnering event, BioPharm America™ 2013, kicks off next week at the Westin Boston Waterfront in Boston, MA. A total of 530 companies, including innovative biotech, pharma and investors, are expected to converge upon Boston for the three-day event held September 17–19.
This includes business development executives from Amgen, AstraZeneca, Bayer, Biogen Idec, EMD Serono, Epizyme, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck, Novo Nordisk, Onyx Pharmaceuticals, Organogenesis, Pfizer, Sanofi, Shire Pharmaceuticals, and Vertex, as well as venture capital firms including 5AM Ventures, Aisling Capital, Atlas Capital, Forbion Capital Partners, Flagship Ventures, Google Ventures, Index Ventures, PureTech Ventures, Rosetta Capital Ltd., Skyline Ventures, SR One, Third Rock Ventures, Wildwood Ventures, and more.
“BioPharm America continues to be the premier biotech and life science partnering event in North America, bringing together pharma leaders from the US and Europe, as well as from other leading global life science regions,” said Florian Schoenhammer, Group Managing Director of EBD Group.
Presenting companies range from preclinical “next generation” companies to mid- and late-stage biotech. A new Academic Innovators™ Showcase presentation track, sponsored by Johnson & Johnson Innovation, will highlight academic research with strong translational potential.
“Johnson & Johnson is committed to fostering early innovation, as demonstrated by our many innovation centers. Our model is built to facilitate close interactions with technical experts and start-up biotech companies, as this gives us access to scientific breakthroughs that have the potential to transition into medicines of the future,” said Robert Urban, Head, Johnson & Johnson Innovation Center, Boston. “As part of our mission, we are proud to encourage collaboration by supporting important initiatives such as BioPharm America’s new Academic Innovators track.”
Other companies featured in the presentation track include clinical stage biotech such as AbGenomics, Anergis SA, Cerecor Inc., Delenex, Embera NeuroTherapeutics, MorphoSys AG, PeriphaGen, Polynoma, Probiodrug AG, Sigma-Tau I.F.R. S.p.A., Supernus Pharmaceuticals, Tocagen Inc., Tracon Pharmaceuticals, Inc., and others, as well as preclinical and innovative next generation companies including Alcyomics Ltd., CEVEC / CAP-CMV, Complexa, Inc., Denovo Biomarkers, Inc., Lipopharma Therapeutics, OntoChem Sialix, and more.
BioPharm America is organized by EBD Group, the leading partnering firm for the life science industry, in collaboration with the Massachusetts Biotechnology Council (MassBio). One-to-one networking at BioPharm America™ is powered by partneringONE®, the leading conference networking solution for the life sciences.
Online registration is still open until September 13, 2013, 12:00 pm PDT, after which all registrations will be handled on site. See registration information online here. MassBio members receive an additional USD 200 discount by adding the code ‘MassBio‘ in the comments field of the online registration form.
Notes to Editors:
Entry to BioPharm America 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BioPharm America conference website atwww.ebdgroup.com/bpa/registration/press_reg.php for press registration details.
Online Press Kit service for BioPharm America™ 2013, is offering services to enhance your public relations efforts.
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
Additional links and information:
Follow BioPharm America 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BPA14)
Or join the Life Science Partnering group on partnering360® to kick off your partnering activities before BioPharm America, and throughout the year. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round. Join the vibrant community of life science companies on partnerning360 today.